Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sartorius AG ST buy Max1111

Start price
€260.00
18.07.23 / 50%
Target price
€300.00
18.07.24
Performance (%)
-28.85%
End price
€185.00
19.07.24
Summary
This prediction ended on 19.07.24 with a price of €185.00. The price of Sartorius AG ST has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.85%. Dividends of €0.74 are taken into consideration when calculating the performance. Max1111 has 50% into this prediction

Sartorius is a German-based biotech and laboratory equipment company that is listed on the Frankfurt Stock Exchange under the symbol SARTF. The company provides products and services for the pharmaceutical, biotech, and food industries, including laboratory instruments, consumables, and services. Sartorius has a global presence with operations in Europe, Asia, and the Americas, and has a strong reputation for innovation, quality, and reliability. The company's stock has performed well in recent years, reflecting its solid financial results and growth prospects in the life sciences industry.

Performance without dividends (%)
Name 1w 1m 1y
Sartorius AG ST -12.137% -12.137% -38.845%
iShares Core DAX® -3.033% -0.013% 11.953%
iShares Nasdaq 100 -3.554% -2.546% 30.128%
iShares Nikkei 225® -3.938% 2.183% 11.741%
iShares S&P 500 -1.517% -0.882% 25.752%

According to Max1111 what are the pros and cons of Sartorius AG ST for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Undervalued
positive Cash Flow expected
Valuable balance sheet
Capable Management
Good culture
Innovative
Growths faster than the competition
Medium risks for its business
Top 10 in its market
Future proof or reliable business model
Cons
Low dividend yield expected

Comments by Max1111 for this prediction

In the thread Sartorius AG diskutieren
Prediction Buy
Perf. (%) -28.85%
Target price 300.000
Change
Ends at 18.07.24

Buy mit Kursziel 300,0

Die letzten Quartalszahlen waren unter den Erwatungen. Sartorius wurde übermässig abgestraft.Turnaroundkandidat

In the thread Trading Sartorius AG
Prediction Buy
Perf. (%) -28.85%
Target price 300.000
Change
Ends at 18.07.24

Die von Max1111 gewählte maximale Laufzeit wurde überschritten